2023
DOI: 10.1016/j.amjoto.2023.103871
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 14 publications
0
1
0
1
Order By: Relevance
“…Given the heterogeneity in the definition of long COVID and evidence indicating that it may comprise several distinct phenotypes (16), we anticipate that some interventions may be better suited for patients with certain phenotypes of long COVID. For example, pulmonary rehabilitation will likely only be effective for patients who are experiencing pulmonary sequelae related to COVID-19, (90), interventions targeting cognitive function will likely only be effective for patients experiencing neurocognitive sequelae related to COVID-19 (91), and interventions aimed at restoring sense of smell will only be effective for patients experiencing anosmia (92). Other interventions may be suitable for patients experiencing general symptoms related to long COVID, such as fatigue, post-exertional malaise, and headaches.…”
Section: Data Synthesis and Analysismentioning
confidence: 99%
“…Given the heterogeneity in the definition of long COVID and evidence indicating that it may comprise several distinct phenotypes (16), we anticipate that some interventions may be better suited for patients with certain phenotypes of long COVID. For example, pulmonary rehabilitation will likely only be effective for patients who are experiencing pulmonary sequelae related to COVID-19, (90), interventions targeting cognitive function will likely only be effective for patients experiencing neurocognitive sequelae related to COVID-19 (91), and interventions aimed at restoring sense of smell will only be effective for patients experiencing anosmia (92). Other interventions may be suitable for patients experiencing general symptoms related to long COVID, such as fatigue, post-exertional malaise, and headaches.…”
Section: Data Synthesis and Analysismentioning
confidence: 99%
“…olfativos em 30 dias, iniciando o quadro de melhora em até 13 dias, mas não houve diferença entre os grupos quando comparado o tempo de recuperação(RASHID et al, 2021).Os corticosteróides podem ter efeitos anti inflamatórios benéficos a curto prazo, reduzindo o processo inflamatório local, principalmente com o uso dos esteróides tópicos 649 ANAIS DO IV CONGRESSO NORTE-NORDESTE DE SAÚDE PÚBLICA (ON-LINE) "A SAÚDE É PARA TODOS" -RESUMOS EXPANDIDOS e intranasais (Além disso, quanto mais precoce for iniciada a terapia nos pacientes melhor o resultado. Outras vantagens do treinamento olfativo estão relacionadas ao seu baixo custo e ausência de efeitos colaterais (KHAN et al, 2022; SCHMIDT, AZAR e GOEKTAS, 2023).tendo resultados positivos com a melhora total ou parcial da anosmia(ABDELAZIM et al, 2022;ABDELAZIM, ABDELAZIM e MONEIR, 2022;IMAM et al, 2023).…”
unclassified